AVNS AVANOS MEDICAL, INC.
Last updated: Mar 16, 2026
Execution Consistency
Did the company actually spend money buying back stock in 3+ of the last 4 quarters?
Bought back stock in 4/4 quarters. Q3 2025: $0M, Q2 2025: $4M, Q1 2025: $9M, Q3 2024: $9M
Execution Acceleration
Is the most recent quarter's buyback spend more than 15% above the trailing average?
Latest quarter $0M vs trailing avg $7M (-99%)
Buyback vs FCF
What percentage of free cash flow is going to buybacks? Bull: 30-80%. Bear: <10% or >80%.
Buyback $22M / FCF $10M = 226% of FCF
Buyback Intensity
How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.
Repurchased 1,370,720 shares = 3.0% of 45,962,627 outstanding (annualized)
Insider Buying
Are officers and directors buying stock with their own money on the open market?
13 open-market purchases by 6 insiders
- BLACKFORD GARY () bought 20,000 shares at $10.97 on 2025-08-13
- BLACKFORD GARY () bought 40,000 shares at $10.99 on 2025-08-13
- Shimer Julie Ann () bought 500 shares at $19.85 on 2024-03-11
- OLEARY PATRICK J () bought 2,447 shares at $31.61 on 2021-09-15
- OLEARY PATRICK J () bought 853 shares at $31.62 on 2021-09-15
- OLEARY PATRICK J () bought 900 shares at $31.65 on 2021-09-15
- OLEARY PATRICK J () bought 800 shares at $31.67 on 2021-09-15
- BLACKFORD GARY () bought 5,000 shares at $29.00 on 2020-05-08
- BLACKFORD GARY () bought 5,000 shares at $28.50 on 2020-05-08
- Woody Joseph Fralin (Chief Executive Officer) bought 3,500 shares at $39.95 on 2019-05-30
Insider-Buyback Convergence
Are insider purchases happening during the same quarters the company is actively buying back stock?
Insider buying coincided with company buybacks in 3 of 4 quarters
- Q3 2025: Shimer Julie Ann bought while company spent $0M
- Q2 2025: Shimer Julie Ann bought while company spent $4M
- Q1 2025: Shimer Julie Ann bought while company spent $9M
Insider Net Direction
Looking at all open-market transactions, are insiders net buyers or net sellers?
Insiders bought $2M, sold $0M (net buying)
Red Flag
Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.
No buyback-insider divergence detected